Additionally, phosphorylated tau in gray matter has been associated with white matter abnormalities and demyelination in AD patients, with these abnormalities appearing prior to the onset of clinical AD symptoms [19], suggesting the importance of oligodendroglia in AD pathogenesis. Here, MAPT is linked to Alzheimer disease.